SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-042126
Filing Date
2023-02-17
Accepted
2023-02-17 17:23:30
Documents
3
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d459172dsc13g.htm SC 13G 58834
2 EX-99.A d459172dex99a.htm EX-99.A 8869
3 EX-99.B d459172dex99b.htm EX-99.B 3165
  Complete submission text file 0001193125-23-042126.txt   72374
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Subject) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88275 | Film No.: 23644107
SIC: 2834 Pharmaceutical Preparations